BackAgile Therapeutics Overview

Agile Therapeutics Long Term Debt

Track Agile Therapeutics's long-term debt ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00
↓ 100.00% YoYΔ $-288000.00 vs prior year quarter

Peer average

Loading

Agile Therapeutics Long Term Debt History

Loading

Agile Therapeutics vs. peers: Long Term Debt Comparison

Loading

Agile Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Agile Therapeutics (AGRX) FAQ

Agile Therapeutics (AGRX) currently reports a long-term debt of $0 as of June 2024. That compares with $290K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Agile Therapeutics's long-term debt history and peer comparisons.

Agile Therapeutics's long-term debt decreased from $290K to $0 — a 100.0% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Agile Therapeutics reported $0 in long-term debt as of June 2024. That compares with $290K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Agile Therapeutics, and consider following AGRX for alerts when major investors trade the stock.

Agile Therapeutics is classified in the Healthcare sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AGRX with unrelated industries.